A detailed history of Bfsg, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Bfsg, LLC holds 2,645 shares of LLY stock, worth $2.06 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares
2,645
Previous 2,610 1.34%
Holding current value
$2.06 Million
Previous $2.36 Million 0.85%
% of portfolio
0.28%
Previous 0.31%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

BUY
$772.14 - $960.02 $27,024 - $33,600
35 Added 1.34%
2,645 $2.34 Million
Q2 2024

Jul 29, 2024

SELL
$724.87 - $909.04 $22,470 - $28,180
-31 Reduced 1.17%
2,610 $2.36 Million
Q1 2024

Apr 23, 2024

BUY
$592.2 - $792.28 $163,447 - $218,669
276 Added 11.67%
2,641 $2.05 Million
Q4 2023

Feb 01, 2024

BUY
$525.19 - $619.13 $690,624 - $814,155
1,315 Added 125.24%
2,365 $1.38 Million
Q3 2023

Oct 20, 2023

BUY
$434.7 - $599.3 $456,435 - $629,265
1,050 New
1,050 $564,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $740B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Bfsg, LLC Portfolio

Follow Bfsg, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bfsg, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bfsg, LLC with notifications on news.